Viewing data from:

CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE

ANDA

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE | A075673 | TARO PHARMACEUTICAL INDUSTRIES LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.2110

per gm

Lowest NADAC/Unit

$0.1878

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
16714049601CLOTRIMAZOLE-BETAMETHASONE CRM	$0.2110	GM	Generic	—	2026-06-17
51672404801CLOTRIMAZOLE-BETAMETHASONE CRM	$0.2110	GM	Generic	—	2026-06-17
16714049602CLOTRIMAZOLE-BETAMETHASONE CRM	$0.1878	GM	Generic	—	2026-06-17
51672404806CLOTRIMAZOLE-BETAMETHASONE CRM	$0.1878	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$2.45

Highest Price

$3.15

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51672-4048-01BETAMETHASONE DIPROPIONATE 0.05%/CLOTRIMAZOLE	$2.45	FSS	Golden State Medical Supply, Inc.	06/14/2028
51672-4048-06BETAMETHASONE DIPROPIONATE 0.05%/CLOTRIMAZOLE	$3.15	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
May 29, 2001	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 0.05% BASE;1%

0 patents0 exclusivities▴

CREAM;TOPICAL | Approved: May 29, 2001

No patent or exclusivity listings for this strength.